Francesco Fiore

Medicine & Life Sciences

1. Hepatocellular Carcinoma 100%
2. Non-Small Cell Lung Carcinoma 82%
3. Yttrium-90 69%
4. Liver 68%
5. Drug Therapy 57%
6. TP protocol 43%
7. Microspheres 42%
8. Radiofrequency Ablation 41%
9. Survival 40%
10. Neoplasms 40%
11. Neoplasm Metastasis 39%
12. Therapeutics 39%
13. Ethanol 36%
14. Radiotherapy 35%
15. SHU 508 32%
16. Doppler Ultrasonography 32%
17. Radionuclide Imaging 30%
18. Pelvic Neoplasms 30%
19. Oxaliplatin 27%
20. Irinotecan 27%
21. Neutropenia 27%
22. Leucovorin 26%
23. Phase II Clinical Trials 25%
24. Spiral Computed Tomography 23%
25. Liver Neoplasms 23%
26. nemorubicin 23%
27. Neuroendocrine Tumors 23%
28. Hemangioma 22%
29. Fluorouracil 21%
30. Injections 20%
31. Epirubicin 20%
32. Recurrence 19%
33. Fibrosis 19%
34. fotemustine 17%
35. Lung Neoplasms 17%
36. Vinorelbine 17%
37. Melanoma 17%
38. Portal Vein 16%
39. Pleural Solitary Fibrous Tumor 16%
40. Granulocyte Colony-Stimulating Factor 15%
41. Cetirizine 15%
42. Ethiodized Oil 15%
43. Osteoid Osteoma 14%
44. Fluorine-18 14%
45. Pharmaceutical Preparations 14%
46. Esophagitis 14%
47. Microwaves 14%
48. Docetaxel 14%
49. gemcitabine 14%
50. Interferons 14%